A new study shows that a 70-year-old malaria drug can block immune cells in the liver so nanoparticles can arrive at their intended tumor site, overcoming a significant hurdle of targeted drug delivery, according to a team of researchers led by Houston Methodist.
Many cancer patients do not respond to chemotherapies because the drugs never reach the cancer cells. Even in nanomedicine, which is one of the best new methods for delivering drugs to a tumor, only about one percent of a dose of nanoparticles will successfully arrive at the intended tumor site, while the rest are filtered out by the immune cells of the liver and spleen.
Using chloroquine, the researchers not only increased the circulation of nanoparticles in the body, but also reduced the body’s filtration of nanoparticles, as well as improved drug delivery to breast tumors. The study was recently published in Scientific Reports, a research journal from the Nature Publishing Group.
Led by Mauro Ferrari, Ph.D., president and CEO of the Houston Methodist Research Institute, and Joy Wolfram, Ph.D. (now at Mayo Clinic’s campus in Jacksonville, Florida), the research showed that chloroquine interfered with immune cells called macrophages, which are used by the body to identify microscopic foreign objects and destroy them.
In this study, mice models received injections of chloroquine, followed by an injection of nanoparticles. Chloroquine decreased the macrophages’ ability to clean up the nanoparticles. The findings are significant, because the nanoparticles not only remained in circulation, but also accumulated in mouse tumors, as well as in the lungs of healthy mice, suggesting that the approach also may enhance treatment for lung diseases.
Chloroquine was invented in the 1940s for the prevention and treatment of malaria. Since it mildly suppresses the immune system, the drug also is used in some autoimmune disorders, such as rheumatoid arthritis and lupus. Apart from this research, the drug is also being studied in other cancers, such as triple-negative breast cancer and pancreatic cancer.
Ferrari, considered one of the founders of nanomedicine and transport oncophysics (the physics of mass transport within a cancer lesion), says researchers and clinicians need to understand the limitations of transport mechanisms to identify effective immunotherapy treatments for patients.
Learn more: AGE-OLD MALARIA TREATMENT FOUND TO IMPROVE NANOPARTICLE DELIVERY TO TUMORS
The Latest on: Drug delivery
[google_news title=”” keyword=”drug delivery” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- York County jury convicts man of murder, drug chargeson March 22, 2023 at 6:23 pm
According to a Facebook post by the York County District Attorney’s Office, Charles Clayton Cassell III was found guilty of third-degree murder, drug delivery resulting in death, possession with ...
- Liposomes Drug Delivery Market Report - Size, Trends 2031on March 22, 2023 at 10:22 am
Liposomes Drug Delivery Market” Understandings Are A Collection Of Information and Analysis Obtained From Diverse ...
- Injectable Drug Delivery Market SWOT Analysis till 2030on March 22, 2023 at 10:16 am
Injectable Drug Delivery Market” Are a Collection of Information and Analysis Obtained From Diverse Sources to ...
- Injectable Drug Delivery Market is anticipated to reach beyond US$ 101.2 Billion by the end of 2033, Persistence Market Researchon March 22, 2023 at 6:35 am
Increasing Prevalence of Chronic Diseases is Driving Growth of the Injectable Drug Delivery MarketNew York, March 22, 2023 (GLOBE NEWSWIRE) -- The Injectable Drug Delivery Market was about US$ 41.5 ...
- Novel Drug Delivery Systems (NDDS) Market Continues Rapid Growth As Demand For Advanced Drug Delivery Technologies Surgeson March 21, 2023 at 5:08 pm
From 2022 to 2027, the demand for novel drug delivery systems (NDDS) is expected to grow significantly at a CAGR of 6.6%. The market for novel drug ...
- Nanotechnology Could Aid Drug Delivery for Lymphedemaon March 21, 2023 at 2:51 am
By using nanotechnology to repair the pumping action of lymphatic vessels, Georgia Institute of Technology researchers have developed a unique approach to treating lymphedema.
- Global Ocular Drug Delivery Devices Market Size To Grow By A CAGR Of ~7% During 2022 2031on March 20, 2023 at 10:38 pm
The global ocular drug delivery devices market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2022 – 2031. The market is segmented by disease type into glaucoma, diabetic ...
- Microneedle Drug Delivery Systems Market to reach US$ 10.9 Billion and expanding at a CAGR of 5.4% from 2023 to 2033 | Persistence Market Researchon March 20, 2023 at 7:40 am
Growing prevalence of transdermal and intradermal drug delivery systems to augment market growthNew York, March 20, 2023 (GLOBE NEWSWIRE) -- The Microneedle Drug Delivery Systems Market revenues were ...
- What’s the Latest in Drug-Delivery Devices?on March 19, 2023 at 5:00 pm
To simplify drug delivery for patients and practitioners, drug-delivery devices are becoming more complex. Many of today’s devices include special features designed to ease self-dosing and encourage ...
- Designing a Drug-Delivery Device? Read This Firston March 19, 2023 at 5:00 pm
Syringes or delivery devices are used with needles to inject the medicine or drug into the body. However, a major challenge is to develop the syringe or delivery device which can be used to deliver ...
via Google News and Bing News